Clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery.

Sectors
Healthcare
Life Sciences
First Invested
2014
Early
Company Status
Acquired
Acquired by Novartis
Associated Team
Edward Mathers